Pediatric pharmaceutical manufacturer focused on China's specialty medicines market
Beimei manufactures specialty pediatric pharmaceuticals for the Chinese market, with a portfolio spanning anti-infection, antivirals, immunology, respiratory, and CNS medicines. The tech stack is manufacturing-centric (HPLC, MES, SCADA, DCS, PLC) rather than software-driven, reflecting a regulated pharma operations focus. Hiring velocity is minimal despite 81 open roles, with research and manufacturing dominating the department mix—consistent with a company scaling production and regulatory compliance (FDA material review, import drug registration, scale-up validation) rather than platform or software engineering.
Notable leadership hires: Investment Director, Registration Department Head, R&D Director, Clinical Director
Shenzhen Beimei Pharmaceutical is a specialty pharma manufacturer based in Shenzhen, Guangdong, focused exclusively on pediatric prescription medicines in China. The company operates a diverse pipeline across multiple therapeutic areas and has established partnerships with international pharmaceutical firms. Active work spans drug import registration, manufacturing scale-up, e-commerce channel development, and FDA material review. The organization is structured around research, manufacturing, and regulatory functions, with ongoing efforts to expand sales channels and secure financing for growth.
Beimei manufactures specialty pediatric prescription medicines for China, with product pipelines in anti-infection, antivirals, immunology, respiratory, gastroenterology, CNS, and hematology. The company partners with international pharma firms.
Shenzhen Beimei Pharmaceutical is headquartered in Shenzhen (深圳市), Guangdong Province (广东省), China.
Other companies in the same industry, closest in size